GFAP and myeloid sarcoma: Many molecules, including neurofilaments (NFs), glial fibrillary acidic protein (GFAP), calcium-binding protein (S100B) and ubiquitin C-terminal hydrolase (UCHL1), have been investigated as potential biomarkers of neurodegeneration in MS.